Minoxidil vs placeboIncidence of serious adverse events · adults with alopecia areata1 finding from 1 reviewTreatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 304 participantsVery low
Summary of findings table ‐ Contact immunotherapy (diphencyprone) + hair growth stimulants (minoxidil) vs contact immunotherapy (diphencyprone)Incidence of serious adverse events · adults with alopecia areata1 finding from 1 reviewTreatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsVery low
Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs hair growth stimulants (minoxidil)Incidence of serious adverse events ‐ not reported · adults with alopecia areataThe review found no eligible studies for this question.1 finding from 1 reviewTreatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found